Endocrine Disorders Archives - Page 221 of 226 - MPR

Endocrine Disorders

Adding Ketamine to Opioids Doesn't Reduce Cancer Pain

Insulin Glargine’s Main Metabolic Effect As Metabolite M1

For patients with type 2 diabetes, following administration of a subcutaneous injection of a therapeutic dose of insulin glargine, glargine is minimally detectable in blood, and most of the plasma insulin concentration is in the form of its metabolite M1.